Obesity and Digestive Disease Unit, Medica Sur Clinic and Foundation, Puente de Piedra 150, col. Toriello Guerra, Mexico City C.P. 14050, Mexico.
Obesity and Digestive Disease Unit, Medica Sur Clinic and Foundation, Puente de Piedra 150, col. Toriello Guerra, Mexico City C.P. 14050, Mexico.
Endocrinol Metab Clin North Am. 2023 Sep;52(3):533-545. doi: 10.1016/j.ecl.2023.01.005. Epub 2023 Mar 15.
Polycystic ovary syndrome (PCOS) affects around 10% of women in the reproductive age group and is characterized by ovulatory dysfunction, hyperandrogenism, and/or polycystic ovarian morphology. PCOS is highly associated with metabolic-associated fatty liver disease (MAFLD) as both diseases share common risk factors. At the time of diagnosis of PCOS, screening for MAFLD is necessary because most patients with MAFLD are asymptomatic. The importance of early detection of MAFLD in patients with PCOS is that a timely intervention in patients with steatosis or steatohepatitis can reduce the probability of liver disease progression.
多囊卵巢综合征（PCOS）影响了大约 10%的育龄期女性，其特征为排卵功能障碍、高雄激素血症和/或多囊卵巢形态。PCOS 与代谢相关脂肪性肝病（MAFLD）高度相关，因为这两种疾病有共同的危险因素。在诊断 PCOS 时，筛查 MAFLD 是必要的，因为大多数 MAFLD 患者无症状。在 PCOS 患者中早期发现 MAFLD 的重要性在于，对脂肪变性或脂肪性肝炎患者进行及时干预可以降低肝病进展的概率。
